July 24, 2009 โ All results from a recent Mayo Clinic study validate the measurement accuracy of the Shape-HF Cardiopulmonary Testing System, a new, noninvasive medical device that assesses heart-lung interaction and ventilation in patients with chronic heart failure and other cardiopulmonary disease.
July 23, 2009 โ The FDAโs Circulatory System Devices Panel today recommended (12-0) conditional approval of a humanitarian device exemption (HDE) for Medtronicโs Melody Transcatheter Pulmonary Valve, for the treatment of children and adults with congenital heart disease.
July 23, 2009 โ Dual-energy CT used as a single examination might be promising for the integrative analysis of the coronary artery morphology and the myocardial blood supply and is in good agreement with angiography and SPECT, according to a study published in this monthโs issue of The American Journal of Cardiology (volume 104, issue 3, pages 318-326, August 2009).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 23, 2009 โ Symphony Medical Inc., a development-stage company focused on novel biopolymer implant therapies to treat cardiac abnormalities, said yesterday it changed the name of the corporation to CardioPolymers Inc.
July 23, 2009 โ St. Jude Medical Inc. this week said it completed enrollment in its European clinical trial to evaluate Trifecta, a stented pericardial tissue aortic valve.
July 23, 2009 โ The FDA recently cleared Ziehm Imagingโs latest mobile C-arm, the Ziehm Vision RFD, which is designed for use in endovascular surgery, interventional cardiology and interventional radiology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 23, 2009 โ Advanced visualization and analysis software company Ziosoft Inc. released the latest version of its 3D thin-client software, adding MR cardiac and CT cardiac function applications.
July 22, 2009 โ The FDA this week approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals.
July 22, 2009 โ W. L. Gore & Associates today said it received FDA approval to market its GORE VIABAHN Endoprosthesis for device diameters 9-13 mm for the treatment of peripheral arterial disease (PAD) in the iliac artery.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 22, 2009 โ Before implementing an electronic health record (EHR) system, providers must first gain control of the number of records, forms and files flowing through the organization, and a recent Xerox Corp. study explained issues involved.
July 22, 2009 โ Cardica Inc. today announced the full results of the PAS-Port system multicenter pivotal trial, known as the EPIC trial, were published in the July issue of the peer-reviewed publication The Journal of Thoracic and Cardiovascular Surgery.
July 22, 2009 โ Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 21, 2009 โ Total procedures performed in angio labs from 2004 to 2008 grew 20 percent, from 4 million in 2004 to 4.8 million procedures in 2008 for hospitals with 150 plus beds, resulting in an average annual growth rate of 4-5 percent, according to a recent report released by IMV.
Jul y 21, 2009 โ St. Jude Medical Inc. today said the FDA cleared its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker). The company also announced FDA and European CE mark approval of version 4.0 of the Merlin.net Patient Care Network (PCN), which supports the Accent RF and Anthem RF devices.
When stenting emerged as a minimally- invasive treatment for clogged arteries associated with peripheral artery disease (PAD), medical experts raised concerns that delivery of stents through the vasculature could potentially knock loose plaque built up on the inside of the artery walls.